BIANCHINI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 12.485
NA - Nord America 11.433
AS - Asia 7.264
SA - Sud America 1.105
AF - Africa 588
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 8
Totale 32.926
Nazione #
US - Stati Uniti d'America 11.091
IT - Italia 8.116
SG - Singapore 2.352
CN - Cina 1.857
HK - Hong Kong 1.145
BR - Brasile 883
SE - Svezia 810
DE - Germania 601
VN - Vietnam 600
FR - Francia 539
NL - Olanda 472
GB - Regno Unito 450
BG - Bulgaria 439
IN - India 275
JP - Giappone 257
CI - Costa d'Avorio 228
CA - Canada 206
RU - Federazione Russa 197
TR - Turchia 174
FI - Finlandia 142
AT - Austria 141
NG - Nigeria 124
ES - Italia 106
BD - Bangladesh 84
RO - Romania 74
IQ - Iraq 71
PL - Polonia 66
PK - Pakistan 59
BE - Belgio 58
MX - Messico 55
AR - Argentina 53
KR - Corea 52
SN - Senegal 48
CH - Svizzera 47
ID - Indonesia 46
MA - Marocco 44
EC - Ecuador 40
CZ - Repubblica Ceca 38
ZA - Sudafrica 38
AU - Australia 37
EG - Egitto 33
UA - Ucraina 32
CO - Colombia 31
PH - Filippine 30
MY - Malesia 27
GR - Grecia 26
SA - Arabia Saudita 26
VE - Venezuela 26
JO - Giordania 23
UZ - Uzbekistan 21
PT - Portogallo 20
CR - Costa Rica 19
IR - Iran 19
LT - Lituania 17
PE - Perù 17
PY - Paraguay 17
AE - Emirati Arabi Uniti 16
EE - Estonia 16
JM - Giamaica 16
TN - Tunisia 16
AL - Albania 15
KZ - Kazakistan 15
UY - Uruguay 15
IL - Israele 14
KE - Kenya 13
AZ - Azerbaigian 12
CL - Cile 12
DZ - Algeria 12
IE - Irlanda 12
NP - Nepal 12
TH - Thailandia 12
BO - Bolivia 10
ET - Etiopia 10
SK - Slovacchia (Repubblica Slovacca) 10
GE - Georgia 9
NO - Norvegia 9
TW - Taiwan 9
BJ - Benin 8
DO - Repubblica Dominicana 8
GT - Guatemala 7
HU - Ungheria 7
OM - Oman 7
PA - Panama 7
PS - Palestinian Territory 7
NZ - Nuova Zelanda 6
QA - Qatar 6
EU - Europa 5
HN - Honduras 5
KG - Kirghizistan 5
AO - Angola 4
BZ - Belize 4
LB - Libano 4
LU - Lussemburgo 4
SV - El Salvador 4
AM - Armenia 3
BS - Bahamas 3
BY - Bielorussia 3
DK - Danimarca 3
LK - Sri Lanka 3
LV - Lettonia 3
Totale 32.880
Città #
Ashburn 1.361
Singapore 1.230
Dallas 1.212
Hong Kong 1.087
Milan 979
Santa Clara 839
San Jose 703
Chandler 672
Fairfield 497
Rome 487
Shanghai 433
Sofia 433
Beijing 387
New York 378
Florence 295
Woodbridge 289
Houston 254
Los Angeles 252
Pisa 247
Abidjan 228
Princeton 221
Wilmington 217
Tokyo 213
Boardman 211
Seattle 209
Lawrence 175
Munich 175
Serra 175
Ho Chi Minh City 162
Lauterbourg 161
Bologna 159
Cambridge 159
Boulder 140
Naples 134
Vienna 125
Medford 120
Ann Arbor 117
Lagos 114
Frankfurt am Main 112
Ottawa 106
Redwood City 104
Hanoi 98
London 96
Council Bluffs 91
Des Moines 86
Dearborn 83
Palermo 82
Redondo Beach 82
Verona 81
Istanbul 79
São Paulo 74
Turin 73
Buffalo 70
Kent 64
Catania 63
Nanjing 57
Paris 53
Helsinki 52
Turku 52
Bari 51
Genoa 51
Lucca 49
Chicago 48
Dakar 48
Ogden 48
Fuzhou 47
Nuremberg 43
San Diego 41
Orem 40
Dong Ket 37
Livorno 35
Warsaw 35
Brescia 33
Rio de Janeiro 33
Columbus 32
Guangzhou 32
Brussels 31
Da Nang 31
Napoli 31
Baghdad 29
Genova 29
Basingstoke 28
Brno 28
Casablanca 28
Iesi 27
Changsha 26
Düsseldorf 26
Hefei 26
Montreal 26
Denver 25
The Dalles 24
Venice 24
Washington 24
Ankara 23
Padova 23
Cagliari 22
Phoenix 22
Quanzhou 22
Toronto 22
Belo Horizonte 21
Totale 18.229
Nome #
DRENAGGIO E DEBRIDEMENT TRANS-GASTRICO ROBOTICO DI “WALLED-OFF PANCREATIC NECROSIS” CON SISTEMA DA VINCI XI E SUTURATRICE ROBOTICA 2.661
INTERVENTO DI APPLEBY CON RESEZIONE TANGENZIALE DEL FONDO GASTRICO CON IL DA VINCI XI PER CARCINOMA DEL PANCREAS LOCALMENTE AVANZATO 2.055
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 960
DUODENOCEFALOPANCREASECTOMIA ROBOTICA CON L’UTILIZZO DEL NUOVO ENDOWRIST VESSEL SEALER PER IL DA VINCI XI 527
CHIRURGIA ROBOTICA MULTIQUADRANTE: AMPUTAZIONE ADDOMINO-PERINEALE COMBINATA AD ENUCLEORESEZIONE DI METASTASI EPATICHE CON LA PIATTAFORMA DA VINCI XI 451
RESEZIONE INTERSFINTERICA DEL RETTO CON COLO-ANO-ANASTOMOSI COMBINATA AD ENUCLEAZIONE DI TUMORE NEUROENDOCRINO DELLA CODA PANCREATICA ROBOT-ASSISTITE CON IL DA VINCI XI E IL TAVOLO OPERATORIO WIRELESS 347
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 334
Zebrafish embryos as avatar of patients with pancreatic cancer: preliminary results of validation a new model toward personalized medicine 317
WALLED-OFF PANCREATIC NECROSIS: DRENAGGIO E DEBRIDMENT TRANS- GASTRICO ROBOTICO CON SISTEMA DA VINCI XI E SUTURATRICE ROBOTICA 298
Clinical impact of routine somatostatin analogues administration after pancreatoduodenectomy: a case-matched comparison according to fistula risk score, ASA and surgical technique 246
EMICOLECTOMIA DESTRA E RESEZIONE DEL SIGMA ROBOT-ASSISTITE COMBINATI CON IL DA VINCI XI E IL TAVOLO OPERATORIO WIRELESS INTEGRATO 243
null 242
Advanced age and high American Society of Anesthesiologists’ risk score do not increase perioperative mortality in pancreatic resections: a view from a tertiary care center 237
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 233
null 230
ROBOTIC PANCREATO-DUODENECTOMY WITH THE USE OF THE NEW ENDO-WRIST VESSEL SEALER EXTEND AND THE DA VINCI TABLE MOTION FOR XI 230
EPATECTOMIA SINISTRA E LINFOADENECTOMIA LOCO-REGIONALE CON IL DA VINCI XI 226
Preliminary experience with Xenotransplantation of pancreatic cancer samples in zebrafish embryos: towards personalized medicine 217
Abdominal ultrasound scan for the follow-up of pancreatic cystic lesions: could it play a role as a safe and cost-saving alternative to the routine MRI? 211
Pancreatic resections for metastases: A twenty-year experience from a tertiary care center 203
The Laparoscopic Tangential Resection of Meckel Diverticulum is Safe and Effective to Remove Ectopic Mucosa 197
New Technologies in Robotic Rectal Resection: da Vinci Xi, Integrated Table Motion, Endowrist Robotic Stapler and Indocyanine Green Fluorescence 197
In Pancreatic Adenocarcinoma Alpha-Synuclein Increases and Marks Peri-Neural Infiltration 193
Pancreatic resections in elderly patients with high American Society of Anesthesiologists’ risk score: a view from a tertiary care center 192
Zebrafish embryo as avatar of oncological patients: preliminary experience toward a personalized medicine 191
The New Robotic Endowrist Stapler and the Bluetooth Integrated Table Motion for the Da Vinci XI: A Combined Right Colectomy and Partial Nephrectomy 190
MAJOR HEPATIC SURGERY WITH THE DA VINCI XI: A ROBOT-ASSISTED LEFT HEPATECTOMY 190
ZEBRAFISH EMBRYO AS AVATAR OF PATIENTS WITH PANCREATIC CANCER: PRELIMINARY EXPERIENCE TOWARD A PERSONALIZED MEDICINE 188
EUS-FNA wet technique for the pre-operative diagnosis of 31 solid pancreatic tumors: Pisa experience 185
DUODENOCEFALOPANCREASECTOMIA ROBOTICA CON L’AUSILIO DEL NUOVO ENDOWRIST VESSEL SEALER PER IL DA VINCI XI 184
Pattern of recurrence and survival after D2 right colectomy for cancer: is there place for a routine more extended lymphadenectomy? 183
Gray-scale, Doppler and contrast-enhanced ultrasound in pancreatic allograft surveillance: A systematic literature review 183
Minimally invasive distal pancreatectomy: a case-matched cost-analysis between robot-assisted surgery and direct manual laparoscopy 182
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 182
Robot-assisted total mesorectal excision for rectal cancer: case-matched comparison of short-term surgical and functional outcomes between the da Vinci Xi and Si 179
First Series of Rectal Resection with the New Robotic Endo-wrist Staplers for da Vinci XI: A Case Match-Study vs Traditional Laparoscopic Staplers 177
RNA-SCOPE TECHNOLOGY AND IMMUNOHISTOCHEMISTRY REVEAL LOW EXPRESSION OF MUC5AC IN METASTATIC PANCREATIC PATIENTS: EPIGENETIC PITFALLS OR A BETTER DISEASE STATUS? 176
Epigenetic expression of MUC5AC in metastatic pancreatic patients using RNA-scope technology and immunohistochemistry 176
A delayed conversion may increase the risk of major complications in acute cholecystitis approached laparoscopically. A retrospective comparative cohort study 175
A case control study comparing the new robotic EndoWrist linear staplers for Da Vinci Xi with traditional laparoscopic staplers in anterior rectal resections 174
COST-ANALYSIS OF ROBOTIC DISTAL PANCREATECTOMY: A COMPARISON BETWEEN ROBOTIC AND DIRECT MANUAL LAPAROSCOPIC APPROACH 174
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine 172
THE USE OF THE NEW ENDOWRIST VESSEL SEALER EXTEND AND THE DA VINCI TABLE MOTION FOR THE DA VINCI XI IN PANCREATO-DUODENECTOMY 172
Full Robotic Colorectal Resections for Cancer Combined With Other Major Surgical Procedures: Early Experience With the da Vinci Xi 171
THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 CAN IDENTIFY PATHOLOGICAL SUBTYPES OF AMPULLARY ADENOCARCINOMAS AND THEIR PROGNOSIS 171
Delaying surgery for patients with a previous SARS-CoV-2 infection 169
UTILIZZO DELLE NUOVE SUTURATRICI LINEARI ROBOTICHE ENDOWRIST PER IL SISTEMA DA VINCI XI NELLA RESEZIONE ANTERIORE DEL RETTO: STUDIO CASO-CONTROLLO DI CONFRONTO CON SUTURATRICI LINEARI LAPAROSCOPICHE TRADIZIONALI 167
Ampullary adenocarcinomas: The immunohistochemical score of CDX2, CK7 and CK 20 identify pathological subtypes and their prognosis 167
Robot-assisted distal pancreatectomy: a comparison between different strategies for the pancreatic stump management 166
ROBOTIC COLORECTAL RESECTION WITH AND WITHOUT THE USE OF THE NEW DA VINCI TABLE MOTION: A CASE MATCHED STUDY 165
A PERSONAL INVAGINATION PANCREATICOJEJUNOSTOMY TECHNIQUE AFTER PANCREATICODUODENECTOMY: DESCRIPTION, TECHNICAL DETAILS AND RESULTS 165
Technical details and preliminary results of a full robotic type II endoleak treatment with the da Vinci Xi 165
Lights and shadows of molecular pathology and immunotherapy in adjuvant setting of patients with pancreatic ductal adenocarcinoma: Tumor volume and microsatellite instability inversely affect early progression free survival 164
ROBOTIC COMBINED HYSTERECTOMY AND RIGHT COLECTOMY USING THE DA VINCI Xi AND THE INTEGRATED TABLE MOTION 163
DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION FOR ISHIKAWA TYPE B ADENOCARCINOMA: UNDERTREATMENT OR NOT? 163
NEW TECHNOLOGIES IN ROBOT-ASSISTED RECTAL RESECTION: TABLE MOTION FOR DA VINCI XI, ENDOWRIST ROBOTIC STAPLERS AND INDOCYANINE GREEN FLUORESCENCE 163
ASPORTAZIONE ROBOT-ASSISITA DI NEUROFIBROMA DELLA RADICE DESTRA DI L3 CON IL DA VINCI XI 163
CHIRURGIA PANCREATICA NEI PAZIENTI ANZIANI CON ALTO RISCHIO ANESTESIOLOGICO: ESPERIENZA DI UN CENTRO DI RIFERIMENTO 162
Control Comparison of the New EndoWrist and Traditional Laparoscopic Staplers for Anterior Rectal Resection with the Da Vinci Xi: A Case Study 161
PROGNOSTIC IMPACT OF CONSERVATIVE SURGERY FOR PANCREATIC IPMNS 161
Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma 161
A case-matched cost-analysis of robot-assisted versus open pancreatoduodenectomy: Can the higher costs of advanced technology be offset by clinical advantages? 161
THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 IDENTIFY PATHOLOGICAL SUBTYPES AND THEIR PROGNOSIS IN AMPULLARY ADENOCARCINOMAS PATIENTS 160
INTERVENTI COMBINATI "COMPLETAMENTE ROBOTICI" CON IL SISTEMA DA VINCI XI: RESEZIONI COLO-RETTALI ASSOCIATE AD ALTRI INTERVENTI DI CHIRURGIA ADDOMINALE MAGGIORE: ASPETTI TECNICI E OUTCOME POST-OPERATORIO 159
Comment on “Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-center experience from southern India” 159
ROBOT-ASSISTED SURGERY FOR COLORECTAL LIVER METASTASIS: A SINGLE CENTER EXPERIENCE 158
Pancreatoduodenectomy without Vascular Resection in Patients with Primary Resectable Adenocarcinoma and Unilateral Venous Contact: A Matched Case Study 157
THE ROUTINE USE OF SOMATOSTATIN ANALOGUES AFTER PANCREATODUODENECTOMY: ITS CLINICAL IMPACT BASED ON A CASE-MATCHED COMPARISON ACCORDING TO FISTULA RISK SCORE, ASA AND SURGICAL TECHNIQUE 156
COMPARISON BETWEEN DIFFERENT STRATEGIES FOR THE PANCREATIC STUMP MANAGEMENT DURING ROBOT-ASSISTED DISTAL PANCREATECTOMY 156
ROBOTIC COLO-RECTAL RESECTION WITH AND WITHOUT THE NEW INTEGRATED TABLE MOTION FOR DA VINCI XI: A CASE MATCHED STUDY 153
Robot-Assisted Treatment of Splenic Artery Aneurysm with Spleen Preservation: Aneurysmectomy and Vascular Reconstruction 153
The occurrence of prion protein in surgically resected pancreatic adenocarcinoma 152
FULL ROBOTIC LEFT HEPATECTOMY WITH REGIONAL LYMPHADENECTOMY USING THE DA VINCI XI PLATFORM 152
ROBOTIC PANCREATO-DUODENECTOMY WITH THE DA VINCI XI: TIPS AND TRICKS FOR AN EASY WORK-FLOW 152
EPATECTOMIA DESTRA ROBOT-ASSISTITA IN PAZIENTE CON ADENOMATOSI EPATICA 151
Robot-assisted pancreatoduodenectomy with the da Vinci Xi: can the costs of advanced technology be offset by clinical advantages? A case-matched cost analysis versus open approach 151
. THE ROLE OF ABDOMINAL ULTRASOUND SCAN FOR THE FOLLOW-UP OF PANCREATIC CYSTIC LESIONS: A COST- SAVING AND SAFE ALTERNATIVE TO THE ROUTINE USE OF MRI? 150
Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrence 150
Perioperative nutritional aspects in total pancreatectomy: A comprehensive review of the literature 150
ROBOT-ASSISTED DISTAL PANCREATECTOMY: DIFFERENT STRATEGIES FOR THE PANCREATIC STUMP MANAGEMENT IN COMPARISON 149
COSTS ANALYSIS OF ROBOTIC RECTAL RESECTION WITH TME: A COMPARISON BETWEEN THE
DA VINCI SI AND XI 148
ROBOTIC LEFT HEPATECTOMY PLUS LOCO-REGIONAL LYMPHADENECTOMY FOR MALIGNANCY USING THE DA VINCI XI 147
CHIRURGIA ROBOT ASSISTITA E LAPAROSCOPICA DEL SURRENE: CONFRONTO TRA TECNICHE MEDIANTE STUDIO CASO-CONTROLLO 146
Robot-Assisted Right Colectomy and Cholecystectomy with Robotic Endowrist Stapler and the Bluetooth Integrated Table Motion for the da Vinci Xi 146
Treatment strategy for pancreatic IPMNs: prognostic impact of conservative surgery 146
Comparison of Short Term Surgical and Functional Outcomes of Robot-Assisted Total Mesorectal Excision for Rectal Cancer with the da Vinci Xi vs Si 144
ISHIKAWA TYPE B ADENOCARCINOMA OF THE PANCREATIC HEAD: DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION AN ONCOLOGICALLY ACCEPTABLE OPTION? 144
PANCREATIC CYSTIC LESIONS’ FOLLOW-UP WITH ABDOMINAL ULTRASOUND SCAN: COULD IT PLAY AN ALTERNATIVE ROLE TO THE ROUTINE USE OF MRI? 144
ROBOTIC LEFT HEPATECTOMY AND REGIONAL LYMPHADENECTOMY WITH DA VINCI XI FOR HEPATOCELLULAR CARCINOMA 144
IS THE ROUTINE USE OF SOMATOSTATIN AFTER PANCREATODUODENECTOMY JUSTIFIED? A CASE- MATCHED COMPARISON ACCORDING TO FISTULA RISK SCORE, ASA SCORE AND SURGICAL TECHNIQUE 144
Robot Assisted Trans-Gastric Drainage of Walled-Off Pancreatic Necrosis with Robotic Endowrist Stapler for the Da Vinci XI 143
MICROSATELLITE INSTABILITY AND TUMOR VOLUME INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 141
Hybrid-Hand Assisted Laparoscopic-Robotic Surgery (HALRS) in Total Proctocolectomy with Ileal Pouch-Anal Anastomosis in Familiar Adenomatous Polyposis 141
NUOVE TECNOLOGIE IN UN CASO DI RESEZIONE ANTERIORE DEL RETTO ROBOTICA CON IL DA VINCI XI 140
ROBOTIC ASSISTED PARTIAL NEPHRECTOMY AND PLEDGETED RENORAPHY 140
COMPARISON BETWEEN ROBOTIC ASSISTED AND THE “GOLD STANDARD” OPEN APPROACH FOR LEFT SIDE CYSTIC TUMOR OF THE PANCREAS: RESULTS FROM A SINGLE CENTER 139
The occurrence of prion protein in surgically resected pancreatic adenocarcinoma 139
EARLY MONOCENTRIC EXPERIENCE IN EUS-FNA WET-TECHNIQUE FOR PANCREATIC LESIONS 138
Is the routine use of somatostatin after pancreatoduodenectomy justified? A case-matched comparison according to fistula risk score, ASA and surgical technique 138
ROBOTIC LEFT-SUBTOTAL SPLENOPANCREATECTOMY FOR A PANCREATIC NECK CARCINOMA 137
Totale 23.425
Categoria #
all - tutte 90.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.704 165 216 109 111 446 358 96 183 185 141 176 518
2022/20233.848 388 386 294 204 383 369 139 317 608 138 470 152
2023/20243.887 318 300 463 302 455 466 318 268 126 180 342 349
2024/20258.559 258 309 271 624 824 916 734 512 970 981 842 1.318
2025/20268.767 697 933 1.200 738 924 659 1.219 431 625 763 332 246
2026/2027171 171 0 0 0 0 0 0 0 0 0 0 0
Totale 33.461